Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability
Saleh Ihmaid, Shaya Y. Al‐Raqa, Mohamed Reda Aouad, et al.
Bioorganic Chemistry (2021) Vol. 111, pp. 104835-104835
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

1,2,3‐Triazole hybrids as anticancer agents: A review
Mohammad Mahboob Alam
Archiv der Pharmazie (2021) Vol. 355, Iss. 1
Closed Access | Times Cited: 200
Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential
Arafa Musa, Hamada S. Abulkhair, Ateyatallah Aljuhani, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 463-463
Open Access | Times Cited: 33
Exploring 1,2,3-triazole-Schiff’s base hybrids as innovative EGFR inhibitors for the treatment of breast cancer: In vitro and in silico study
Nareman A. Nawareg, Asmaa S. A. Yassen, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108106-108106
Closed Access
Discovery of novel tris-1,2,3-triazole-based hybrids as VEGFR2 inhibitors with potent anti-proliferative and cytotoxicity through apoptosis induction
Mosa Alsehli, Adeeb Al Sheikh Ali, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108131-108131
Closed Access
Design, synthesis, and apoptotic antiproliferative action of new benzimidazole/1,2,3-triazole hybrids as EGFR inhibitors
Abubakar Ahmed, Anber F. Mohammed, Zainab M. Almarhoon, et al.
Frontiers in Chemistry (2025) Vol. 12
Open Access
Small Molecular Oligopeptides Adorned with Tryptophan Residues as Potent Antitumor Agents: Design, Synthesis, Bioactivity Assay, Computational Prediction, and Experimental Validation
Hongyu Xu, Tong Li, Qi Wang, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
A novel class of phenylpyrazolone-sulphonamides rigid synthetic anticancer molecules selectively inhibit the isoform IX of carbonic anhydrases guided by molecular docking and orbital analyses
Maan T. Khayat, Hany E. A. Ahmed, Abdelsattar M. Omar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 24, pp. 15243-15261
Closed Access | Times Cited: 14
Copper supported modified magnetic carrageenan as a bio-based catalyst for the synthesis of novel scaffolds bearing the 1,2,3-triazole unit through the click reaction
Nima Khaleghi, Maryam Esmkhani, Milad Noori, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 9, pp. 2337-2349
Open Access | Times Cited: 5
Synthesis, antiproliferative, docking and DFT studies of benzimidazole derivatives as EGFR inhibitors
Hessah Abdullah Alzahrani, Mohammad Mahboob Alam, Ahmed A. Elhenawy, et al.
Journal of Molecular Structure (2021) Vol. 1253, pp. 132265-132265
Closed Access | Times Cited: 33
N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity
Aeshah A. Awaji, Waheed Ali Zaki El Zaloa, Mohamed A. Seleem, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107228-107228
Closed Access | Times Cited: 3
EGFR as therapeutic target to develop new generation tyrosine kinase inhibitors against breast cancer: A critical review
Ruby Mariam Raju, Jeffin Joy A, Raghavendra Nulgumnalli Manjunathaiah, et al.
Results in Chemistry (2024) Vol. 7, pp. 101490-101490
Open Access | Times Cited: 3
Exploring of N-phthalimide-linked 1,2,3-triazole analogues with promising ­anti-SARS-CoV-2 activity: synthesis, biological screening, and molecular modelling studies
Ateyatallah Aljuhani, Mosa Alsehli, Mohamed A. Seleem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3
Discovery of triaromatic flexible agents bearing 1,2,3-Triazole with selective and potent anti-breast cancer activity and CDK9 inhibition supported by molecular dynamics
Saleh Ihmaid, Ateyatallah Aljuhani, Mosa Alsehli, et al.
Journal of Molecular Structure (2021) Vol. 1249, pp. 131568-131568
Closed Access | Times Cited: 29
Cell Cycle Arrest and Apoptosis-Inducing Ability of Benzimidazole Derivatives: Design, Synthesis, Docking, and Biological Evaluation
Syed Nazreen, Abdulraheem S. A. Almalki, Serag Eldin I. Elbehairi, et al.
Molecules (2022) Vol. 27, Iss. 20, pp. 6899-6899
Open Access | Times Cited: 18
Exploring the dual effect of novel 1,4-diarylpyranopyrazoles as antiviral and anti-inflammatory for the management of SARS-CoV-2 and associated inflammatory symptoms
Azizah M. Malebari, Hany E. A. Ahmed, Saleh Ihmaid, et al.
Bioorganic Chemistry (2022) Vol. 130, pp. 106255-106255
Open Access | Times Cited: 18
Phthalimides Represent a Promising Scaffold for Multi‐Targeted Anticancer Agents
Balaji Wamanrao Matore, Purusottam Banjare, Ajay Singh Sarthi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Closed Access | Times Cited: 9
Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological Evaluation
Fawzia Faleh Albelwi, Mohamed Teleb, Marwa M. Abu‐Serie, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10324-10324
Open Access | Times Cited: 23
Synthesis, Characterization and Nanoformulation of Novel Sulfonamide-1,2,3-triazole Molecular Conjugates as Potent Antiparasitic Agents
Faizah S. Aljohani, Nadjet Rezki, Mohamed Reda Aouad, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4241-4241
Open Access | Times Cited: 17
Phthalimide/Naphthalimide containing 1,2,3-triazole hybrids: Synthesis and Antimicrobial Evaluation
Priyanka Yadav, C. P. Kaushik, Mukesh Kumar, et al.
Journal of Molecular Structure (2022) Vol. 1276, pp. 134688-134688
Closed Access | Times Cited: 17
Design of new hybrids indole/phthalimide/oxadiazole-1,2,3 triazole agents and their anticancer properties
Hanan A. Mohamed, Mohamed S. Bekheit, Ewies F. Ewies, et al.
Journal of Molecular Structure (2022) Vol. 1274, pp. 134415-134415
Closed Access | Times Cited: 16
Benzimidazole-1,2,3-triazole-piperazine hybrids: design, synthesis, antidiabetic evaluation and molecular modelling studies
Laxmi Deswal, Vikas Verma, Jagat Singh Kirar, et al.
Research on Chemical Intermediates (2022) Vol. 49, Iss. 3, pp. 1059-1083
Closed Access | Times Cited: 15
Discovery of novel VEGFR2-TK inhibitors by phthalimide pharmacophore based virtual screening, molecular docking, MD simulation and DFT
Balaji Wamanrao Matore, Partha Pratim Roy, Jagadish Singh
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 13056-13077
Closed Access | Times Cited: 8
Unveiling the anti-cancer potentiality of phthalimide-based Analogues targeting tubulin polymerization in MCF-7 cancerous Cells: Rational design, chemical Synthesis, and Biological-coupled Computational investigation
Ateyatallah Aljuhani, Mohamed S. Nafie, Nader R. Albujuq, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107827-107827
Closed Access | Times Cited: 2
Novel Oleanolic Acid-Phtalimidines Tethered 1,2,3 Triazole Hybrids as Promising Antibacterial Agents: Design, Synthesis, In Vitro Experiments and In Silico Docking Studies
Ghofrane Lahmadi, Mabrouk Horchani, Amal Dbeibia, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4655-4655
Open Access | Times Cited: 7
The anti‐breast cancer therapeutic potential of 1,2,3‐triazole‐containing hybrids
Juntao Song, Shuai Zhang, Bo Zhang, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top